St. Louis, MO; Huntsville, AL- Sigma-Aldrich and Oxford BioMedica have filed suit in US District Court against Open Biosystems. The suit alleges that Open Biosystems’ products, including the Lentiviral shRNAmir Library, infringe two patents covering lentiviral-based systems for the delivery of foreign DNA to mammalian cells that Sigma-Aldrich exclusively licensed for research use from Oxford […]
CARLSBAD, Calif. & HAYWARD, Calif. & CAMBRIDGE, United Kingdom–Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Solexa, Inc. (Nasdaq:SLXA), a provider of next-generation genetic analysis systems, announced a collaboration through which Invitrogen will supply many of the reagents for Solexa’s sequencing, gene expression, and small RNA […]
Shiga, Japan: La Jolla, CA-Takara Bio and Stratagene have settled their patent disputes regarding enzyme blends used in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing […]
DANVERS, Mass.—Cell Signaling Technology, Inc. (CST), announced that it has entered into a new partnership agreement with Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics. Under the new agreement, CST will develop antibodies for kinase activation and protein phosphorylation assays that will be […]
Shiga, Japan,: La Jolla, CA-Takara Bioand Stratagene have settled their patent disputes regarding enzyme blendsused in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing revenue,” stated […]
PALO ALTO, Calif. & PARIS–Agilent Technologies Inc. (NYSE:A) and ExonHit Therapeutics (Euronext:ALEHT) announced that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products. These SpliceArrays include GPCR, Ion Channel, nuclear receptors and apoptosis pathways. SpliceArrays are a new generation of […]
FOSTER CITY, Calif. & BEVERLY, Mass.—Applied Biosystems Group (NYSE: ABI – News), an Applera Corporation business, and Agencourt Personal Genomics (APG) announced they have signed a definitive agreement whereby Applied Biosystems will acquire APG, a privately held developer of next-generation genetic analysis technologies, for approximately $120 million in cash. The transaction is subject to regulatory […]
South Australian biotechnology company, TGR BioSciences Pty Ltd, has secured a long term licensing agreement with PerkinElmer, Inc., a leading US technology company that will provide worldwide distribution of TGR’s new generation of drug screening kits. TGR’s SureFire™ ERK assay kits use cutting-edge proprietary technology that helps pharmaceutical and biotechnology companies as well as research […]
San Francisco, CA – Dr. Chi Yang, the CEO of SynPep, a provider of custom peptide synthesis and antibody research products, was indicted by a federal grand jury on 13 counts of mail fraud and false statements for falsifying the purity levels of the company’s peptide products. The indictment claims that under Dr. Yang’s supervision, […]
Chalfont St Giles, UK and Philadelphia, PA – General Electric and MDS Pharma Services announced the availability of a new, automated in vitro micronucleus assay that incorporates GE Healthcare’s IN Cell 1000 and IN Cell 3000 high content analysis platforms. This automated imaging assay enables an accurate, early assessment of the potential genotoxicity of novel […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
